Two Sigma Investments LP Has $4.30 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Two Sigma Investments LP grew its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 153.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 219,839 shares of the company's stock after purchasing an additional 133,239 shares during the period. Two Sigma Investments LP owned approximately 0.18% of Privia Health Group worth $4,298,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Teza Capital Management LLC boosted its position in Privia Health Group by 6.1% during the 4th quarter. Teza Capital Management LLC now owns 30,884 shares of the company's stock worth $604,000 after acquiring an additional 1,777 shares during the period. State of Wyoming boosted its position in Privia Health Group by 125.0% during the 4th quarter. State of Wyoming now owns 18,227 shares of the company's stock worth $356,000 after acquiring an additional 10,126 shares during the period. ProShare Advisors LLC raised its stake in shares of Privia Health Group by 44.5% during the 4th quarter. ProShare Advisors LLC now owns 30,770 shares of the company's stock worth $602,000 after purchasing an additional 9,475 shares in the last quarter. Nuveen Asset Management LLC raised its stake in shares of Privia Health Group by 19.8% during the 4th quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock worth $29,110,000 after purchasing an additional 246,393 shares in the last quarter. Finally, Occudo Quantitative Strategies LP purchased a new stake in shares of Privia Health Group during the 4th quarter worth about $207,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Price Performance

Shares of PRVA stock traded up $0.07 during trading on Monday, reaching $22.83. The company had a trading volume of 938,228 shares, compared to its average volume of 740,286. The firm's 50 day simple moving average is $23.34 and its two-hundred day simple moving average is $22.74. Privia Health Group, Inc. has a one year low of $16.37 and a one year high of $26.09. The company has a market capitalization of $2.78 billion, a PE ratio of 228.32, a PEG ratio of 3.47 and a beta of 0.87.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on PRVA. JPMorgan Chase & Co. raised their price target on Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 price target on shares of Privia Health Group in a research note on Thursday, April 10th. JMP Securities reaffirmed a "market outperform" rating and set a $29.00 price target on shares of Privia Health Group in a research note on Monday, April 28th. Piper Sandler raised their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. Finally, Canaccord Genuity Group raised their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Privia Health Group currently has a consensus rating of "Buy" and an average price target of $27.77.

Insider Activity at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 15,100 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $352,283.00. Following the transaction, the chief executive officer now directly owns 454,281 shares of the company's stock, valued at $10,598,375.73. The trade was a 3.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Matthew Shawn Morris sold 10,309 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $240,508.97. Following the completion of the transaction, the director now directly owns 59,792 shares in the company, valued at approximately $1,394,947.36. This represents a 14.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 51,579 shares of company stock valued at $1,226,367. Corporate insiders own 10.70% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.